Terms: = Bone cancer AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1 AND Treatment
112 results:
1. Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 years.
Blay JY; Tlemsani C; Toulmonde M; Italiano A; Rios M; Bompas E; Valentin T; Duffaud F; Le Nail LR; Watson S; Firmin N; Dubray-Longeras P; Ropars M; Perrin C; Hervieu A; Lebbe C; Saada-Bouzid E; Soibinet P; Fiorenza F; Bertucci F; Boudou P; Vaz G; Bonvalot S; Honoré C; Marec-Berard P; Minard V; Cleirec M; Biau D; Meeus P; Babinet A; Dumaine V; Carriere S; Fau M; Decanter G; Gouin F; Ngo C; Le Loarer F; Karanian M; Meurgey A; Dufresne A; Brahmi M; Chemin-Airiau C; Ducimetiere F; Penel N; Le Cesne A;
Eur J Cancer; 2024 Jan; 196():113454. PubMed ID: 38008029
[TBL] [Abstract] [Full Text] [Related]
2. Clinical Predictors of Survival in Patients With BRAFV600-Mutated Metastatic Melanoma Treated With Combined BRAF and MEK Inhibitors After Immune Checkpoint Inhibitors.
Kahn AM; Perry CJ; Etts K; Kluger H; Sznol M
Oncologist; 2024 Apr; 29(4):e507-e513. PubMed ID: 37971411
[TBL] [Abstract] [Full Text] [Related]
3. Cost-Effectiveness Modeling of Prostate-Specific Membrane Antigen Positron Emission Tomography with Piflufolastat F 18 for the Initial Diagnosis of Patients with Prostate cancer in the United States.
Yee CW; Harvey MJ; Xin Y; Kirson NY
Pharmacoeconomics; 2024 Feb; 42(2):231-247. PubMed ID: 37934376
[TBL] [Abstract] [Full Text] [Related]
4. Multiplex immunohistochemistry elucidates increased distance between cytotoxic T cells and plasma cells in relapsed myeloma, and identifies Lag-3 as the most common checkpoint receptor on cytotoxic T cells of myeloma patients.
Ninkovic S; Purton LE; Harrison SJ; Quach H
Haematologica; 2024 May; 109(5):1487-1500. PubMed ID: 37855027
[TBL] [Abstract] [Full Text] [Related]
5. treatment Refractoriness in Chronic Lymphocytic Leukemia: Old and New Molecular Biomarkers.
Maher N; Mouhssine S; Matti BF; Alwan AF; Gaidano G
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373521
[TBL] [Abstract] [Full Text] [Related]
6. Therapies for acute myeloid leukemia in patients ineligible for standard induction chemotherapy: a systematic review.
Heuser M; Fernandez C; Hauch O; Klibanov OM; Chaudhary T; Rives V
Future Oncol; 2023 Apr; 19(11):789-810. PubMed ID: 37170899
[TBL] [Abstract] [Full Text] [Related]
7. Nuclear Export Inhibitors Selinexor (KPT-330) and Eltanexor (KPT-8602) Provide a Novel Therapy to Reduce Tumor Growth by Induction of PANoptosis.
Camilli S; Lockey R; Kolliputi N
Cell Biochem Biophys; 2023 Sep; 81(3):421-426. PubMed ID: 37126200
[TBL] [Abstract] [Full Text] [Related]
8. Plasma hPG
Prieur A; Harper A; Khan M; Vire B; Joubert D; Payen L; Kopciuk K
BMC Cancer; 2023 Apr; 23(1):305. PubMed ID: 37016331
[TBL] [Abstract] [Full Text] [Related]
9. Cross-cultural adaptation and validation of simplified Chinese version of the Spine Oncology Study Group Outcomes Questionnaire (SOSGOQ) 2.0 with its assessment in clinical setting.
Yin M; Sun Z; Ding X; Wang T; Sun Y; Li L; Gao X; Ma J; Huang Q; Xiao J; Mo W
Spine J; 2022 Dec; 22(12):2024-2032. PubMed ID: 36031097
[TBL] [Abstract] [Full Text] [Related]
10. Chrysin sensitizes osteosarcoma cells against TRAIL-induced apoptosis.
Xie B; Yang J; Zhang J
Cell Biol Int; 2022 Nov; 46(11):1825-1833. PubMed ID: 35979647
[TBL] [Abstract] [Full Text] [Related]
11. Head-to-head comparison of
Huo H; Shen S; He D; Liu B; Yang F
Prostate Cancer Prostatic Dis; 2023 Mar; 26(1):16-24. PubMed ID: 35931759
[TBL] [Abstract] [Full Text] [Related]
12. Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.
Patel A; Kalachand R; Busschots S; Doherty B; Kapros E; Lawlor D; Hall N; Stordal BK
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD008766. PubMed ID: 35866378
[TBL] [Abstract] [Full Text] [Related]
13. Phase 1 Study of No-Carrier Added 177Lu-DOTATATE (SNU-KB-01) in Patients with Somatostatin Receptor-Positive Neuroendocrine Tumors: The First Clinical Trial of Peptide Receptor Radionuclide Therapy in Korea.
Ryoo HG; Suh M; Kang KW; Lee DW; Han SW; Cheon GJ
Cancer Res Treat; 2023 Jan; 55(1):334-343. PubMed ID: 35468268
[TBL] [Abstract] [Full Text] [Related]
14. Prevalence of mental disorders in patients with cancer compared to matched controls - secondary analysis of two nationally representative surveys.
Vehling S; Mehnert-Theuerkauf A; Philipp R; Härter M; Kraywinkel K; Kuhnert R; Koch U
Acta Oncol; 2022 Jan; 61(1):7-13. PubMed ID: 34731069
[TBL] [Abstract] [Full Text] [Related]
15. Minimally invasive plate osteosynthesis with locking plate for metastatic humeral fractures.
Matsumura T; Saito T; Akiyama T; Takeshita K
J Orthop Sci; 2022 Nov; 27(6):1309-1314. PubMed ID: 34579991
[TBL] [Abstract] [Full Text] [Related]
16. The smac mimetic LCL161 targets established pulmonary osteosarcoma metastases in mice.
Harris MA; Shekhar TM; Miles MA; Cerra C; Hawkins CJ
Clin Exp Metastasis; 2021 Oct; 38(5):441-449. PubMed ID: 34398333
[TBL] [Abstract] [Full Text] [Related]
17. Physical, emotional and social pain communication by patients diagnosed and living with multiple myeloma.
Quinn B; Ludwig H; Bailey A; Khela K; Marongiu A; Carlson KB; Rider A; Seesaghur A
Pain Manag; 2022 Jan; 12(1):59-74. PubMed ID: 34139887
[No Abstract] [Full Text] [Related]
18. An expert consensus report on mycosis fungoides in Italy: epidemiological impact and diagnostic-therapeutic pathway.
Alberti Violetti S; Alaibac M; Ardigò M; Baldo A; DI Meo N; Massone C; Onida F; Simontacchi G; Zalaudek I; Pimpinelli N; Quaglino P; Berti E
Ital J Dermatol Venerol; 2021 Aug; 156(4):413-421. PubMed ID: 34037370
[TBL] [Abstract] [Full Text] [Related]
19. bone Metastases, Skeletal-Related Events, and Survival in Patients With Metastatic Non-Small Cell Lung cancer Treated With Immune Checkpoint Inhibitors.
Qin A; Zhao S; Miah A; Wei L; Patel S; Johns A; Grogan M; Bertino EM; He K; Shields PG; Kalemkerian GP; Gadgeel SM; Ramnath N; Schneider BJ; Hassan KA; Szerlip N; Chopra Z; Journey S; Waninger J; Spakowicz D; Carbone DP; Presley CJ; Otterson GA; Green MD; Owen DH
J Natl Compr Canc Netw; 2021 Apr; 19(8):915-921. PubMed ID: 33878726
[TBL] [Abstract] [Full Text] [Related]
20. Selinexor decreases HIF-1α via inhibition of CRM1 in human osteosarcoma and hepatoma cells associated with an increased radiosensitivity.
von Fallois M; Kosyna FK; Mandl M; Landesman Y; Dunst J; Depping R
J Cancer Res Clin Oncol; 2021 Jul; 147(7):2025-2033. PubMed ID: 33856525
[TBL] [Abstract] [Full Text] [Related]
[Next]
